Colossal Biosciences
Status
ACTIVE
Global HQ
Texas, United States
Countries of investment
- USA
Investment stages
- Series A
- Series B
Industries
- Media
- Web3
- Blockchain
- Biotechnology
- Gaming
- Cryptocurrency
- AdTech
- Legal Services
About
Colossal Biosciences focuses on advancing de-extinction efforts by utilizing gene editing technology to resurrect the Woolly Mammoth, aiming to restore lost ecosystems and promote biodiversity.
Colossal Biosciences focuses on advancing de-extinction efforts by utilizing gene editing technology to resurrect the Woolly Mammoth, aiming to restore lost ecosystems and promote biodiversity.
Investment Thesis
They Focus on advancing cuttingedge biotechnology and deextinction projects, aiming to bring back extinct species and restore ecosystems through breakthrough genetic engineering.
Manager's Experience
Backed by over a decade of experience, the fund manager has developed a robust portfolio across technology, healthcare, and consumer sectors. Operating primarily in North America and Europe, they have successfully closed more than 50 deals, showcasing a strong focus on early to growth-stage investments. Their strategic approach is data-driven, emphasizing thematic trends that align with emerging market demands. Notable exits include several high-profile IPOs, underscoring a proven track record for generating substantial returns.
Colossal Biosciences Contacts Information
Primary contact
Team
Amanda Bastawros